Immunological predictors in children with hypoxic-ischemic encephalopathy
ALLERGOLOGY AND IMMUNOLOGY IN PEDIATRICS | COMMUNICATIONS AND CORRESPONDENCE
Volume 69 • Issue 2 • June 2022, pp. 38-40
Publication date: 15.06.2022
E.S. Kuzmina, L.Yu. Barycheva, O.V. Agranovich, A.S. Idrisova
Stavropol State Medical University, 310, Mira st., Stavropol, 355002, Russia
References
1. Каркашадзе ГА, Аникин АВ, Зимина ЕП, Давыдова ИВ, Каримова ХМ [и др.]. Современные данные о патогенезе и лечении гипоксически-ишемических поражений головного мозга у новорожденных. Педиатрическая фармакология. 2016; 13 (5): 452–467. [Karkashadze GA, Anikin AV, Zimina EP, Davydova IV, Karimova KhM [i dr.]. Recent Information on the Pathogenesis and Treatment of Hypoxic-Ischemic Brain Lesions in Newborns. Pediatricheskaya farmakologiya. 2016; 13 (5): 452–467. (In Russ.)] https://doi.org/10.15690/pf.v13i5.1641
2. Boskabadi H, Moradi A, Zakerihamidi M. Interleukins in diagnosis of perinatal asphyxia: A systematic review. Int J Reprod Biomed (Yazd). 2018; 17 (5): 303–314. https://doi.org/ 10.18502/ijrm.v17i5.4598
3. Jiang LJ, Xu ZX, Wu MF, Dong GQ, Zhang LL [et al.]. Resatorvid protects against hypoxic-ischemic brain damage in neonatal rats. Neural Regen Res. 2020; 15 (7): 1316–1325. https://doi.org/10.4103/1673-5374.272615
4. Grasselli C. Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation / C. Grasselli, D. Ferrari, C. Zalfa, M. Soncini, G. Mazzoccoli, F.A. Facchini, L. Marongiu, F. Granucci, M. Copetti, A.L. Vescovi, F. Peri, L. De Filippis. Cell Death Dis. 2018. Vol. 15. № 9 (3). P. 280.
5. Федеральное руководство по детской неврологии / Под редакцией профессора Гузевой В.И. М.: ООО «МК», 2016. 656 с. [Federal’noe rukovodstvo po detskoy nevrologii / Pod redaktsiey professora Guzevoy V.I. M.: OOO «MK», 2016. 656 s. (In Russ.)].
6. Debillon T, Bednarek N, Ego A. LyTONEPAL: longterm outcome of neonatal hypoxic encephalopathy in the era of neuroprotective treatment with hypothermia: a French population-based cohort. BMC Pediatr. 2018; 18: 255. https://doi.org/10.1186/s12887-018-1232-6
7. Барычева ЛЮ, Идрисова АС, Кузьмина ЕС, Агранович ОВ. Клиническое значение провоспалительных интерлейкинов у новорожденных с гипоксически-ишемическим поражением ЦНС. Медицинский вестник Северного Кавказа. 2021; 16 (3): 310–312. [Barycheva LYu, Idrisova AS, Kuzmina ES, Agranovich OV. Clinical significance of proinflammatory interleukins in newborns with hypoxic-ischemic CNS damage. Meditsinskiy vestnik Severnogo Kavkaza — Medical News of North Caucasus. 2021; 16 (3): 310–312. (In Russ.)] https://doi.org/10.14300/mnnc.2021.16074
Citation
Kuzmina ES, Barycheva LYu, Agranovich OV, Idrisova AS. Immunological predictors in children with hypoxic-ischemic encephalopathy. Allergology and Immunology in Pediatrics. 2022; 2: 38-40. (In Russ.) https://doi.org/10.53529/2500-1175-2022-2-38-40
This work is licensed under a Creative Commons Attribution- ShareAlike 4.0 International License